Company / Gross Profit
NEUROONE MEDICAL TECHNOLOGIES Corp Gross Profit History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.1M
FY2025
5-year range
-$97.7K / $1.1M
FY2021-FY2025
Trend
+136.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 3 consecutive years, from -$97,749 in FY2022 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025.
Improved from -$70,794 to $1M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's gross profit has grown for 3 consecutive years.
- In FY2025, gross profit increased 136.5% year-over-year.
- Lowest gross profit in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +136.5% |
| FY2024 | $456.5K | +744.9% |
| FY2023 | -$70.8K | +27.6% |
| FY2022 | -$97.7K | +0.0% |
| FY2021 | -$97.7K | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | $3.3K | +179.3% |
| FY2011 | $1.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026